LENSAR Inc reported Q1 2025 revenue of $14.159 million, representing a YoY rise of 33.7% but a QoQ decline of 15.4% from Q4 2024. The gross margin stands solid at 50.3% on a gross profit of $7.125 million, underscoring the product’s underlying margin profile. However, the quarter delivered a sizable operating loss of $5.558 million and a net loss of $27.345 million, largely driven by a substantial non-operating expense line (-$21.787 million) that dominated the bottom line. Operating expenses totaled $12.683 million, with R&D at $1.534 million and SG&A (selling, general and administrative) at $11.149 million, indicating a high burn on go-to-market and administration relative to revenue. Free cash flow was negative at $6.944 million, and cash from operations was -$6.939 million. The company ended the period with $19.547 million in cash and cash equivalents and a net debt position of -$17.074 million, while stockholders’ equity remained negative at -$22.141 million, signaling balance sheet leverage despite a moderate cash runway. Management commentary (where available) would be expected to emphasize progress in installed base, system adoption, and near-term initiatives to scale revenue, though profitability remains a work in progress. Overall, the QQ1 results reflect a growth trajectory in revenue with meaningful margin relief on the core product but ongoing earnings volatility tied to non-operating costs and near-term cash burn.